Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06326905
Other study ID # IRB00437750
Secondary ID K23DK133677-01A1
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 1, 2024
Est. completion date July 1, 2026

Study information

Verified date May 2024
Source Johns Hopkins University
Contact Samantha Curriero, MPH
Phone 4436991220
Email scurrie6@jh.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist and 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist population. It consists of two phases- an open label pilot and a randomized waitlist control trial.


Description:

CAPABLE is a multicomponent goal-directed program that reduces physical disability by working with the person and environment but has not been explored in prehabilitation research. The purpose of this study is to adapt CAPABLE, an existing evidence-based program for functionally and socio-economically vulnerable older adults, as a prehabilitation intervention for people with frailty awaiting KT. As in CAPABLE, the delivery characteristics of CAPABLE Kidney Transplant consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW). In earlier phases, research team members conducted preliminary activities to design the CAPABLE Kidney Transplant intervention using Human-Centered Design techniques. This study will seek to accomplish two aims: 1. To iteratively refine the CAPABLE -Transplant prototype for those currently KT inactive. - 2. To pilot test the CAPABLE-Transplant intervention The investigators will collect feedback during the open label pilot to further refine the intervention that will be tested as part of the randomized control trial.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 33
Est. completion date July 1, 2026
Est. primary completion date September 1, 2025
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - Deceased Donor Waitlist - =50 years old - Community dwelling - Current Inactive status or active and had been inactive in the last 18 months for cardiovascular disease, frailty, obesity, social support, mental health, incomplete testing. Exclusion Criteria: - Living Donor Waitlist - Severe cognitive impairment - Inactivity expected to last > 3 months (eg cancer treatment) - >4 hospitalizations in the last 12 months - Current home nursing, physical or occupational therapy

Study Design


Intervention

Behavioral:
CAPABLE Transplant- Open Label Pilot
As in CAPABLE, the delivery characteristics of CAPABLE Transplant consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for = 1hour), a registered nurse (RN) (~4 home visits for = 1hour) and a handy worker (HW). Adaptations targeting those currently KT inactive will be made on a per-client basis as part of the open-label pilot. We will further refine and develop the intervention by receiving feedback from the open label pilot participants and CAPABLE clinicians who implemented the pilot to gain their perspective of the acceptability and feasibility of implementing the CAPABLE-Transplant intervention. Based on this feedback, the study team will have developed an adapted iteration of the prototype.
CAPABLE Transplant- Randomized Control Trial
As in CAPABLE, the delivery characteristics of CAPABLE Transplant consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for = 1hour), a registered nurse (RN) (~4 home visits for = 1hour) and a handy worker (HW). Refinements based on the open label pilot results will be included.

Locations

Country Name City State
United States Johns Hopkins School of Nursing Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
Johns Hopkins University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Acceptability at endpoint of intervention assessed by survey Score on Likert scale-based questions re: program content & structure satisfaction, willingness to recommend. Survey developed by study team. 16 weeks
Other Feasibility as assessed by qualitative questions Open/ Close Ended Questions, Recruitment Rate, Completion Rate, Data Collection Rate, Mean time for survey administration, Withdrawal Rate, Cost. Questions developed by study team. 16 weeks
Other Fidelity as assessed by percent completion of intervention items % tasks/ patient- directed content delivery per session for Nurse & Occupational Therapist, % completion of home modifications 16 weeks
Primary Waitlist-status as assessed by data obtained by the National Kidney Registry Death (any cause), Time Inactive
Change of waitlist status (inactive to active, delisting)
0, 16 weeks, 32 weeks
Secondary Change in self-efficacy as assessed by the Coping Self-Efficacy Instrument Coping Self-Efficacy is a 13 item instrument on a scale of 0 ('can't do at all') to 10 ('certain can do'). A higher score indicates higher level of self-efficacy when implementing coping strategies. Score range 0-130. Baseline, 16 weeks, 32 weeks
Secondary Change in self-efficacy as assessed by the Self-Efficacy of Chronic Disease Management Instrument Self-Efficacy of Chronic Disease Management Instrument is a 6 item instrument on a visual analog scale, ranging from 1 (not at all confident) to 10 (totally confident). Lower scores indicate lower self-efficacy as indicated by confidence. Score range 6-60. Baseline, 16 weeks, 32 weeks
Secondary Change in Pain as assessed by the Brief Pain Inventory The Brief Pain Inventory - is a 4-item self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning. The patient is asked to rate their worst, least, average, and current pain intensity, list current treatments and their perceived effectiveness, and rate the degree that pain interferes with general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life on a 10 point scale. For the 10 point scale, 0 indicated no pain and 10 indicates the worst imaginable pain. Score range 0-40. Baseline, 16 weeks, 32 weeks
Secondary Change in Depression as assessed by the Patient Health Questionnaire Depression Scale (PHQ-8) The PHQ-8 contains 8 questions, with a 0-3 scale. A score of 10 or greater is considered major depression, 20 or more is severe major depression. Score range 0-30. Baseline, 16 weeks, 32 weeks
Secondary Change in Social engagement as assessed by the Lubben Social Network Scale The Lubben Social Network Scale is a 7-item questionnaire that measures the size of social networks of family and friends. The score ranges between 0 and 30, with higher scores indicated more social engagement. Baseline, 16 weeks, 32 weeks
Secondary Change in Social engagement as assessed by the Krause-Borawski-Clark Support Interactions Scale The Krause-Borawski-Clark Support Interactions Scale is a 10-item self-reported questionnaire that measures social interactions. The scale is broken down into different domains; scores range from very often (4); fairly often (3); once in a while (2); never (1) or binary-- satisfied (1) or not satisfied (0) depending on domain within the questionnaire. Items are summed to form a single composite score range 10-40, Higher scores on the scale is associated with better personal perception and social support. Baseline, 16 weeks, 32 weeks
Secondary Change in Fatigue/Quality of Life as assessed by the Kidney disease Quality of Life Scale The Kidney disease Quality of Life Short Form is a 20-item self-report outcome measure for patients on dialysis. Higher scores indicate better health-related quality of life. Scores range from 0-100. Baseline, 16 weeks, 32 weeks
Secondary Change in Frailty as assessed by the Fried Frailty Phenotype The Fried Frailty Phenotype contains 5 criteria: unintentional weight loss >10lbs >5% of body mass in the last year, weakness (handgrip strength measurement), exhaustion (based on the Center for Epidemiological Studies Depression Scale), slow gait (walking time over a distance), and low physical activity. People who had none of the criteria were considered non-frail, people who had 1 and 2 criteria were considered pre-frail, and people who had =3 criteria were considered frail. Baseline, 16 weeks, 32 weeks
Secondary Change in Health Team Communication as assessed by the CollaboRATE Scale Measure The CollaboRATE scale measure is a 3 item self-report questionnaire on patient's shared decision making. It is scored on a 10-point anchored scale, ranging from 0 ("no effort was made") to 9 ("every effort was made"). Higher scores indicate more shared decision making. Baseline, 16 weeks, 32 weeks
Secondary Change in Function as assessed by Lawton & Brody's assessment of Instrumental Activities of Daily Living Scale The assessment contains 8 questions with answers that are either a score of 0 or 1. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women, and 0 through 5 for men to avoid potential gender bias. Baseline, 16 weeks, 32 weeks
Secondary Change in Function as assessed by the Katz Index of Independence in Activities of Daily Living 6 questions, each 1 point for a total score of 6. A score closer to 6 indicates high patient independence. Baseline, 16 weeks, 32 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A